CWM
XERS icon

CIBC World Markets’s Xeris Biopharma Holdings XERS Stock Holding History

CIBC World Markets’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$79.7K Buy
+10,158
New +$79.9K ﹤0.01% 1182
2025
Q2 		$86.3K Sell
18,473
-12,642
-41% -$57.9K ﹤0.01% 1423
2025
Q1 		$171K Buy
31,115
+17,992
+137% +$72.6K ﹤0.01% 1508
2024
Q4 		$44.5K Buy
+13,123
New +$42.2K ﹤0.01% 1266

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIBC World Markets's XERS Position: Q4 2025 in Review

CIBC World Markets opened a new position in Xeris Biopharma Holdings (XERS) in Q4 2025: 10,158 shares worth $79.7K. The stake represents ﹤0.01% of the portfolio and ranks #1182 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in XERS as recently as Q2 2025.

CIBC World Markets first reported a position in XERS in Q4 2024 and has held it in 4 quarters since. The position peaked at $171K in Q1 2025. 225 funds tracked by Wall St. Rank hold XERS as of Q4 2025.

  • CIBC World Markets held 10,158 shares of Xeris Biopharma Holdings worth $79.7K as of Q4 2025.
  • Xeris Biopharma Holdings was a new CIBC World Markets position in Q4 2025.
  • Xeris Biopharma Holdings made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1182 holding.
  • CIBC World Markets first reported a position in Xeris Biopharma Holdings in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Xeris Biopharma Holdings position peaked at $171K in Q1 2025.
  • 225 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.